Chargement en cours...
Evaluation of Anti-SARS-Cov-2 S-RBD IgG Antibodies after COVID-19 mRNA BNT162b2 Vaccine
(1) Background: The evaluation of anti-spike protein receptor-binding domain (S-RBD) antibodies represents a useful tool to estimate the individual protection against Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) infection; (2) Methods: We evaluated anti S-RBD IgG levels by indirect c...
Enregistré dans:
| Publié dans: | Diagnostics (Basel) |
|---|---|
| Auteurs principaux: | , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8306884/ https://ncbi.nlm.nih.gov/pubmed/34206567 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diagnostics11071135 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|